Health In Tech, Inc. (HIT) · Oct 16, 2026 · Delisting

Health In Tech faces Nasdaq delisting risk on two fronts

Nasdaq deficiencies — Board cure tied to Nov. 10, 2026 meeting; bid-price cure deadline Apr. 12, 2027

Health In Tech’s Nasdaq notices expose a new $1 bid-price breach alongside a known board gap, putting a reverse split on the table.

Health In Tech is an AI-enabled InsurTech platform building a digital marketplace for employers, brokers, carriers, and third-party administrators; it is still scaling that platform while dealing with carrier-onboarding delays and modest first-half revenue contraction. The filing adds a second, more market-sensitive listing problem. The board and audit-committee shortfall was already disclosed after Sanjay Shrestha’s August 10 resignation, and the company had already telegraphed a proposed independent director at the annual meeting. The new information is that Nasdaq has also found the stock below its $1 minimum bid requirement for 30 consecutive business days: “the closing bid price for the Class A common stock was below the minimum $1.00 per share requirement.” The immediate risk is contained, but the compliance burden is now real. Neither notice immediately removes the Nasdaq listing, and the company has until April 12, 2027 to cure the bid-price issue; however, a reverse stock split is explicitly being considered if the share price does not recover. That creates a potential capital-structure action that was not part of the previously disclosed governance fix. The governance gap is likely fixable at the scheduled meeting. The company says the 2026 Annual Meeting is scheduled for November 10, 2026 and expects a new independent director to be elected and added to the Audit Committee. 〔0〕 Bottom line: The board deficiency was mostly known, but the new bid-price notice materially worsens the listing story by adding reverse-split and eventual delisting risk. This is a negative change to the company’s situation even though neither issue has an immediate effect on trading or listing.⟧src: The letter has no immediate effect on the listing or trading of the Company’s Class A common stock⟧

What to watch next

November 10, 2026 annual meeting and director election

Original filing on SEC EDGAR

More Health In Tech, Inc. news

Health In Tech faces Nasdaq delisting risk on two fronts | HIT Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.